A strong all-round H1 19 performance from Rentokil, driven by contributions came from all regions and core businesses – the accelerated top-line growth in hygiene was quite positive. Management has maintained the full-year guidance. We will revise our estimates upwards, incorporating the strong momentum and value-accretive CWS deal.